AtriCure, Inc. (ATRC) Operating Margin
- Operating margin · 12 months: Value 2.26%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2.26% | Operating income / revenue. Period ending 2026-06-30. $12.89M ÷ $569.62M × 100 ≈ 2.26% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 12.89M USD | Operating Income (Loss) |
| Revenue | 569.62M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 98.03M USD | Research and Development Expense |
| Selling, general and administration | 323.69M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12.89M | $569.62M | (m) | $98.03M | $323.69M | 2.26% |
| 2026-03-31 | $-2.97M | $552.16M | (m) | $100.92M | $319.51M | -0.54% |
| 2025-12-31 | $-9.45M | $534.53M | (m) | $99.21M | $311.02M | -1.77% |
| 2025-09-30 | $-26.46M | $518.30M | (m) | $109.66M | $304.86M | -5.11% |
| 2025-06-30 | $-34.07M | $499.95M | (m) | $107.73M | $299.87M | -6.82% |
| 2025-03-31 | $-35.05M | $480.08M | (m) | $98.86M | $295.07M | -7.30% |
| 2024-12-31 | $-40.01M | $465.31M | (m) | $96.18M | $291.36M | -8.60% |
| 2024-09-30 | $-34.16M | $447.57M | (m) | $82.02M | $286.86M | -7.63% |
| 2024-06-30 | $-34.84M | $429.95M | (m) | $81.41M | $275.23M | -8.10% |
| 2024-03-31 | $-31.82M | $414.60M | (m) | $78.43M | $265.41M | -7.67% |
| 2023-12-31 | $-26.68M | $399.25M | (m) | $73.92M | $253.14M | -6.68% |
| 2023-09-30 | $-22.15M | $380.73M | (m) | $66.87M | $240.95M | -5.82% |
| 2023-06-30 | $-24.79M | $365.69M | (m) | $61.68M | $236.62M | -6.78% |
| 2023-03-31 | $-34.30M | $349.30M | (m) | $59.03M | $235.22M | -9.82% |
| 2022-12-31 | $-42.67M | $330.38M | (m) | $57.34M | $231.27M | -12.92% |
| 2022-09-30 | $-51.03M | $315.57M | (m) | $57.40M | $229.48M | -16.17% |
| 2022-06-30 | $58.36M | $302.78M | (m) | $53.51M | $216.99M | 19.27% |
| 2022-03-31 | $56.94M | $289.63M | (m) | $50.92M | $211.56M | 19.66% |
| 2021-12-31 | $55.20M | $274.33M | (m) | $48.51M | $204.65M | 20.12% |
| 2021-09-30 | $50.20M | $258.84M | (m) | $45.57M | $195.15M | 19.40% |
| 2021-06-30 | $-52.46M | $243.13M | (m) | $44.86M | $188.98M | -21.58% |
| 2021-03-31 | $-44.66M | $212.58M | (m) | $42.70M | $156.93M | -21.01% |
| 2020-12-31 | $-44.23M | $206.53M | $655.00K | $43.07M | $150.47M | -21.42% |
| 2020-09-30 | $-42.06M | $210.13M | (m) | $45.30M | $148.41M | -20.01% |
| 2020-06-30 | $-46.70M | $211.98M | (m) | $44.87M | $154.94M | -22.03% |
| 2020-03-31 | $-43.26M | $230.07M | (m) | $44.64M | $167.96M | -18.80% |
| 2019-12-31 | $-33.12M | $230.81M | $635.00K | $41.23M | $162.23M | -14.35% |
| 2019-09-30 | $-20.40M | $222.38M | (m) | $36.59M | $147.97M | -9.17% |
| 2019-06-30 | $-17.81M | $215.71M | (m) | $34.99M | $141.13M | -8.26% |
| 2019-03-31 | $-13.02M | $208.60M | (m) | $33.84M | $131.66M | -6.24% |
| 2018-12-31 | $-17.13M | $201.63M | $785.00K | $34.72M | $129.52M | -8.49% |
| 2018-09-30 | $-16.66M | $194.80M | (m) | $33.99M | $123.88M | -8.55% |
| 2018-06-30 | $-17.45M | $187.01M | (m) | $33.40M | $120.24M | -9.33% |
| 2018-03-31 | $-24.77M | $180.44M | (m) | $33.65M | $121.77M | -13.73% |
| 2017-12-31 | $-24.98M | $174.72M | (m) | $34.14M | $117.00M | -14.30% |
| 2017-09-30 | $-30.54M | $169.81M | (m) | $36.29M | $116.63M | -17.98% |
| 2017-06-30 | $-29.98M | $166.00M | (m) | $36.59M | $112.31M | -18.06% |
| 2017-03-31 | $-31.36M | $160.44M | (m) | $36.81M | $109.75M | -19.55% |
| 2016-12-31 | $-31.14M | $155.11M | (m) | $35.82M | $106.42M | -20.07% |
| 2016-09-30 | $-34.07M | $149.81M | (m) | $33.73M | $108.10M | -22.74% |
| 2016-06-30 | $-33.91M | $142.90M | (m) | $31.96M | $104.71M | -23.73% |
| 2016-03-31 | $-31.00M | $135.81M | (m) | $28.70M | $99.35M | -22.82% |
| 2015-12-31 | $-26.72M | $129.75M | (m) | $25.74M | $93.85M | -20.59% |
| 2015-09-30 | $-20.87M | $123.31M | (m) | $22.97M | $85.65M | -16.92% |
| 2015-06-30 | $-15.54M | $118.56M | (m) | $21.50M | $78.21M | -13.11% |
| 2015-03-31 | $-13.58M | $112.49M | (m) | $20.21M | $73.20M | -12.07% |
| 2014-12-31 | $-16.36M | $107.45M | (m) | $18.60M | $73.51M | -15.23% |
| 2014-09-30 | $5.36M | $99.92M | (m) | $17.25M | $70.17M | 5.37% |
| 2014-06-30 | $3.55M | $93.39M | (m) | $15.46M | $69.57M | 3.80% |
| 2014-03-31 | $4.77M | $87.31M | (m) | $13.94M | $66.22M | 5.46% |
| 2013-12-31 | $10.89M | $81.89M | (m) | $13.44M | $57.01M | 13.30% |
| 2013-09-30 | $-7.91M | $78.37M | (m) | $12.76M | $52.04M | -10.09% |
| 2013-06-30 | $-7.82M | $74.36M | (m) | $12.43M | $49.15M | -10.52% |
| 2013-03-31 | $-7.50M | $72.20M | (m) | $12.26M | $46.59M | -10.39% |
| 2012-12-31 | $-7.20M | $70.25M | (m) | $12.15M | $45.06M | -10.25% |
| 2012-09-30 | $-7.04M | $68.65M | (m) | $12.14M | $43.65M | -10.26% |
| 2012-06-30 | $-5.70M | $67.73M | (m) | $12.31M | $41.68M | -8.42% |
| 2012-03-31 | $-5.15M | $66.24M | (m) | $12.30M | $40.71M | -7.78% |
| 2011-12-31 | $-4.73M | $64.40M | (m) | $11.86M | $39.87M | -7.35% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-3.19M | $59.01M | (m) | $11.53M | $37.05M | -5.41% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-15.51M | $54.53M | (m) | $11.41M | $35.11M | -28.44% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |